Profile
Corporate information
Official name
Balyasny Asset Management LP
Registration country
Official name
Balyasny Asset Management LP
Registration country
Investment activity status
Active investor
Funds managed
| Fund | Type | Vintage |
|---|---|---|
| Atlas Enhanced Fund LP |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Pharmacopeia Inc |
United States | 1 Jul 2005 | Venture |
|
|
|
Callisto Pharmaceuticals Inc Public biotechnology company that develops novel therapeutics to treat cancer. |
United States | N/A Active |
||
|
|
Nutrition 21 LLC Nutritional bioscience company. |
United States | N/A |
||
|
|
Acorda Therapeutics Inc A biotechnology company whose mission is to develop and market therapeutic products for spinal cord injury and other central nervous system disorders. |
United States | N/A Active |
||
|
|
Hana Biosciences Inc Biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to strengthen the foundation of cancer care. |
United States | N/A |
||
|
|
Keryx Biopharmaceuticals Inc |
United States | N/A Active |
||
|
|
Curon Medical Inc |
United States | N/A |
||
|
|
Optimer Pharmaceuticals Inc Global biopharmaceutical company. |
United States | N/A |
||
|
|
Inhibitex Inc |
United States | N/A |